Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amer M. Zeidan

Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy

Clinical Lymphoma, Myeloma and Leukemia

English

Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?

Therapeutic Advances in Hematology

Hematology

2019

English

Related publications

Outpatient Management of Acute Promyelocytic Leukemia After Consolidation Chemotherapy

English

Acute-Onset Hypokalemic Paralysis With Arsenic Trioxide Therapy in Patient With Acute Promyelocytic Leukemia

Journal of Community and Supportive Oncology

Oncology

Hematology

2016

English

Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia

English

Arsenic Trioxide-Based Therapy Is Suitable for Patients With Psoriasis-Associated Acute Promyelocytic Leukemia – A Retrospective Clinical Study

Hematology

2016

English

Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide

English

Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’

English

Anthracycline-Based Consolidation May Determine Outcome of Post-Consolidation Immunotherapy in AML

Leukemia and Lymphoma

English

Arsenic Trioxide (ATO) and MEK1 Inhibition Synergize to Induce Apoptosis in Acute Promyelocytic Leukemia Cells

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amer M. Zeidan

Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy

Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?

Related publications

Outpatient Management of Acute Promyelocytic Leukemia After Consolidation Chemotherapy

Acute-Onset Hypokalemic Paralysis With Arsenic Trioxide Therapy in Patient With Acute Promyelocytic Leukemia

Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia

Arsenic Trioxide-Based Therapy Is Suitable for Patients With Psoriasis-Associated Acute Promyelocytic Leukemia – A Retrospective Clinical Study

Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide

Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives

‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’

Anthracycline-Based Consolidation May Determine Outcome of Post-Consolidation Immunotherapy in AML

Arsenic Trioxide (ATO) and MEK1 Inhibition Synergize to Induce Apoptosis in Acute Promyelocytic Leukemia Cells